Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruixiulin vs NovoRapid in type 1 or 2 diabetes mellitus
CTR20131062Phase 3Active
- Start
- Oct 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of myl-1601d in diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM). Started Oct 2013; status: active.
02
Drugs
myl-1601d
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20131062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131062.